BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo-Reference-Cited by-同舟云学术

BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo

Published:2007-02 Issue:4 Volume:17 Page:316-322
ISSN:0960-9822
Container-title:Current Biology
language:en
Short-container-title:Current Biology

Author:

Steegmaier Martin,Hoffmann Matthias,Baum Anke,Lénárt Péter,Petronczki Mark,Krššák Martin,Gürtler Ulrich,Garin-Chesa Pilar,Lieb Simone,Quant Jens,Grauert Matthias,Adolf Günther R.,Kraut Norbert,Peters Jan-Michael,Rettig Wolfgang J.

Publisher

Elsevier BV

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology

Reference25 articles.

1. Polo-like kinases and the orchestration of cell division;Barr;Nat. Rev. Mol. Cell Biol.,2004

2. Polo-like kinases (Plks) and cancer;Takai;Oncogene,2005

3. Targeting polo-like kinase 1 for cancer therapy;Strebhardt;Nat. Rev. Cancer,2006

4. Polo-like kinases: A team in control of the division;van de Weerdt;Cell Cycle,2006

5. Sak, a murine protein-serine/threonine kinase that is related to the Drosophila polo kinase and involved in cell proliferation;Fode;Proc. Natl. Acad. Sci. USA,1994

Cited by 738 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Balancing Plk1 activity levels: The secret of synchrony between the cell and the centrosome cycle;BioEssays;2024-08-11

2. Targeting polo-like kinase 1: advancements and future directions in anti-cancer drug discovery;Expert Opinion on Drug Discovery;2024-07-29

3. p53 protein abundance is a therapeutic window across TP53 mutant cancers and is targetable with proximity inducing small molecules;2024-07-27

4. PLK-1 regulates MEX-1 polarization in theC. eleganszygote;2024-07-26

5. Prediction of the Potential Efficacy of Dlx5 in Immunotherapy for Hypopharyngeal Cancer through Integrated Bulk and Single-Cell RNA Sequencing;2024-07-18